Co-production of blaVIM-2 and blaIMP-18 in an Extensively Drug-Resistant Clinical Isolate of Pseudomonas aeruginosa from Ecuador.
The goal of this study is the first report of a Pseudomonas aeruginosa strain harboring such co-production of blaVIM-2 and blaIMP-18 in Ecuador. The proliferation of Extensively Drug-Resistant strains ofPseudomonas aeruginosa has contributed to increased mortality rates and prolonged hospital stays.